Bone marrow mesenchymal stem cell-derived exosomes alleviating sepsis-induced lung injury by inhibiting ferroptosis of macrophages
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2025.114789 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Huimin Deng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, 200433, China; Key Laboratory of Anesthes…. Hauptthemen laut MEDLINE: Exosomes, Ferroptosis, Sepsis, Mesenchymal Stem Cells. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Health Commission.
Themen: Sepsis
Abstract (Originalsprache)
OBJECTIVE: To investigate whether bone marrow mesenchymal stem cells derived exosomes (BMSCs-exo) can alleviate sepsis-induced lung injury and its related mechanism by inhibiting ferroptosis of macrophages. METHODS: RAW264.7 cells were first stimulated with lipopolysaccharide (LPS) to observe whether macrophage ferroptosis occurred. After pre-treating BMSCs with the exosome inhibitor GW4869, the lung-protective effect was observed to determine if it was eliminated. Furthermore, BMSCs-exo was extracted to clarify if it could exert effects like BMSCs. Finally, key molecules responsible for the effects were identified through sequencing and other related techniques. RESULTS: Following stimulation with LPS, the expression of GPX4 in RAW264.7 cells decreased significantly, while the expression of PTGS2 increased significantly. The intracellular GSH content decreased, while MDA content increased. BMSCs-exo reversed the decrease in GPX4 and increase in PTGS2, increased GSH and decreased MDA. Sequencing revealed that lncRNA SNHG12 in macrophages was significantly upregulated after co-culture with BMSCs-exo. Knockdown of lncRNA SNHG12 in BMSCs via siRNA resulted in a significant decrease in the inhibitory effect on macrophage ferroptosis both in vivo and in vitro. CONCLUSION: BMSCs-exo can inhibit macrophage ferroptosis through lncRNA SNHG12, thereby alleviating the sepsis-induced lung injury and improving the survival rate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, 200433, China; Key Laboratory of Anesthesiology (Shanghai Jiao Tong University), Ministry of Education, China;…
- Department of Anesthesiology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, 200433, China; Shanghai Institute of Acupuncture and Anesthesia, Shanghai, 200433, China.
Förderung
- National Natural Science Foundation of China
- Shanghai Municipal Health Commission
Zitieren
APA
Deng, H., Zhou, W., Wei, J., Jin, T., Chen, Y., Zhu, L., Yang, H., & Lv, X. (2025). Bone marrow mesenchymal stem cell-derived exosomes alleviating sepsis-induced lung injury by inhibiting ferroptosis of macrophages. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114789
Vancouver
Deng H, Zhou W, Wei J, Jin T, Chen Y, Zhu L, et al. Bone marrow mesenchymal stem cell-derived exosomes alleviating sepsis-induced lung injury by inhibiting ferroptosis of macrophages. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.114789
BibTeX
@article{Deng2025,
author = {Deng, Huimin and Zhou, Wenyu and Wei, Juan and Jin, Tian and Chen, Yuanli and Zhu, Lina and Yang, Hao and Lv, Xin},
title = {Bone marrow mesenchymal stem cell-derived exosomes alleviating sepsis-induced lung injury by inhibiting ferroptosis of macrophages},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2025.114789}
}
EUVIMED